調查批次:CHT2014-02 | 檢體寄出日期:2014-02-24 | 報告回收截止日期:2014-03-03 | 回收份數:21 |
T3 檢驗院際品管調查結果: | ||
2.歷次品管檢體 T3 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 2 |
2 |
5 |
162 |
-8.0 |
-4.7 |
-0.6 |
0.1 |
-20 |
210 |
3.0 |
1.4 |
0.2 |
1.0 |
6 |
RH07b | RH07 | 1 |
2 |
3 |
165 |
-5.0 |
-2.9 |
-0.4 |
0.4 |
-12 |
185 |
-22.0 |
-10.6 |
-1.3 |
-0.7 |
-44 |
RH14 | RH14 | 3 |
2 |
3 |
159 |
-11.0 |
-6.5 |
-0.8 |
-0.1 |
-27 |
194 |
-13.0 |
-6.3 |
-0.8 |
-0.1 |
-26 |
RH15 | RH15 | 3 |
2 |
8 |
144 |
-26.0 |
-15.3 |
-1.9 |
-1.1 |
-64 |
176 |
-31.0 |
-15.0 |
-1.9 |
-1.2 |
-62 |
CL009 | CL009 | 3 |
2 |
5 |
167 |
-3.0 |
-1.8 |
-0.2 |
0.5 |
-7 |
207 |
0.0 |
0.0 |
0.0 |
0.8 |
0 |
CL010 | CL010 | 2 |
2 |
6 |
210 |
40.0 |
23.5 |
2.9 |
3.5 |
98 |
298 |
91.0 |
44.0 |
5.5 |
6.7 |
183 |
CL012 | CL012 | 4 |
2 |
3 |
158 |
-12.0 |
-7.1 |
-0.9 |
-0.1 |
-29 |
191 |
-16.0 |
-7.7 |
-1.0 |
-0.3 |
-32 |
CL013 | CL013 | 3 |
2 |
5 |
173 |
3.0 |
1.8 |
0.2 |
0.9 |
7 |
198 |
-9.0 |
-4.3 |
-0.5 |
0.2 |
-18 |
CL014a | CL014 | 3 |
2 |
3 |
152 |
-18.0 |
-10.6 |
-1.3 |
-0.6 |
-44 |
188 |
-19.0 |
-9.2 |
-1.1 |
-0.5 |
-38 |
CL015 | CL015 | 2 |
2 |
5 |
141 |
-29.0 |
-17.1 |
-2.1 |
-1.3 |
-71 |
180 |
-27.0 |
-13.0 |
-1.6 |
-1.0 |
-54 |
Median of RIA Group |
161 |
193 |
||||||||||||||
Range of RIA Group |
141 - 210 |
176 - 298 |
||||||||||||||
Robust mean of RIA Group |
160 ( n = 10 ) |
195 ( n = 10 ) |
||||||||||||||
Robust SD of RIA Group |
14.1 |
15.3 |
||||||||||||||
CV of RIA Group |
8.8% |
7.8% |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 1 |
4 |
9 |
162 |
-8.0 |
-4.7 |
-0.6 |
-0.6 |
-20 |
188 |
-19.0 |
-9.2 |
-1.1 |
-1.4 |
-38 |
RH02c | RH02 | 1 |
4 |
1 |
175 |
5.0 |
2.9 |
0.4 |
0.3 |
12 |
215 |
8.0 |
3.9 |
0.5 |
0.6 |
16 |
RH06 | RH06 | 1 |
4 |
9 |
149 |
-21.0 |
-12.4 |
-1.5 |
-1.4 |
-51 |
174 |
-33.0 |
-15.9 |
-2.0 |
-2.4 |
-66 |
RH07a | RH07 | 1 |
4 |
2 |
184 |
14.0 |
8.2 |
1.0 |
0.8 |
34 |
214 |
7.0 |
3.4 |
0.4 |
0.5 |
14 |
RH12 | RH12 | 2 |
4 |
2 |
173 |
3.0 |
1.8 |
0.2 |
0.1 |
7 |
210 |
3.0 |
1.4 |
0.2 |
0.2 |
6 |
RH19 | RH19 | 2 |
4 |
2 |
170 |
0.0 |
0.0 |
0.0 |
-0.1 |
0 |
205 |
-2.0 |
-1.0 |
-0.1 |
-0.1 |
-4 |
RH20 | RH20 | 3 |
4 |
7 |
196 |
26.0 |
15.3 |
1.9 |
1.6 |
64 |
245 |
38.0 |
18.4 |
2.3 |
2.8 |
76 |
CL005 | CL005 | 1 |
4 |
9 |
147 |
-23.0 |
-13.5 |
-1.7 |
-1.5 |
-56 |
199 |
-8.0 |
-3.9 |
-0.5 |
-0.6 |
-16 |
CL006a | CL006 | 1 |
4 |
1 |
176 |
6.0 |
3.5 |
0.4 |
0.3 |
15 |
209 |
2.0 |
1.0 |
0.1 |
0.1 |
4 |
CL008 | CL008 | 1 |
4 |
2 |
175 |
5.0 |
2.9 |
0.4 |
0.3 |
12 |
214 |
7.0 |
3.4 |
0.4 |
0.5 |
14 |
CL011 | CL011 | 0 |
4 |
13 |
171 |
1.0 |
0.6 |
0.1 |
0.0 |
2 |
212 |
5.0 |
2.4 |
0.3 |
0.4 |
10 |
Median of CLIA Group |
173 |
210 |
||||||||||||||
Range of CLIA Group |
147 - 196 |
174 - 245 |
||||||||||||||
Robust mean of CLIA Group |
171 ( n = 11 ) |
207 ( n = 11 ) |
||||||||||||||
Robust SD of CLIA Group |
15.5 |
13.8 |
||||||||||||||
CV of CLIA Group |
9.1% |
6.7% |
||||||||||||||
Median of All Labs |
167 |
205 |
||||||||||||||
Range of All Labs |
141 - 210 |
174 - 298 |
||||||||||||||
Robust mean of All Labs |
166 ( n = 21 ) |
201 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
15.8 |
17.7 |
||||||||||||||
CV of All Labs |
9.5% |
8.8%
|
||||||||||||||
Certified assigned value ( Xa )( ng/dL ) |
170 |
207 |
||||||||||||||
Expanded uncertainty ( Ua ) |
1.7 |
3.3 |
||||||||||||||
Relative expanded uncertainty |
1.0% |
1.6% |
||||||||||||||
Coverage factor k |
2.6 |
2.6 |
||||||||||||||
Effective degrees of freedom veff |
5 |
5 |
||||||||||||||
SD for proficiency assessment ( σp ) |
13.6 |
16.6 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL014a, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL006a, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL014a, |
Immunotech |
5 |
RH01b, CL009, CL013, CL015, |
MP |
6 |
CL010, |
Siemens ADVIA Centaur |
7 |
RH20, |
Siemens COAT-A-COUNT |
8 |
RH15, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2014-03-27